Docs know and reps know the pricing is wrong. Hello, analysts, are you listening? Al, this pricing/insurance situation is akin to having two runners. Management thinks their Trulance runner is faster and better, and will win the race no matter what. So they put a backpack filled with rocks (higher pricing) on their guy just to prove to the world he is the better runner. Why not flat out win the race against Linzess, even up, so there is no disadvantage with 3rd party payers? This is something SGYP can control. Maybe during the next conference call, an analyst will ask these kind of questions. These dummies could save perhaps $120MM a year in marketing expenses. Who knows, even the board might be awake and listening this time around.
